PROTEOMICS OF TEAR IN INACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY

被引:0
|
作者
Jiang, L. [1 ]
Wei, R. [1 ]
Diao, J. [1 ]
Ding, H. [1 ]
Wang, W. [1 ]
Ao, R. [1 ]
机构
[1] Tongji Univ, Tongji Hosp, Sch Med, Dept Ophthalmol, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
Tear proteomics; Thyroid-associated ophthalmopathy; Inactive stage; Bioinformatics; GRAVES OPHTHALMOPATHY; HORMONE; ORBITOPATHY; DISEASE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Thyroid-associated ophthalmopathy (TAO), one of the most common orbital diseases in adults, seriously reduces patients' quality of life. Although human tear proteomics identified many abnormal expressed proteins and proposed several pathogeneses of TAO, most of these studies focused on the active stage or mixed types in TAO. In this study we identified significantly changed proteins and preliminary revealed the potential signalling pathways and mechanisms of TAO with the late, inactive stage. Patients and Methods. Tears from TAO patients (n=6) with a CAS score < 3 and 6 control healthy subject were collected. The pooled tears were further fractionated using high pH reversed-phase chromatography, then submitted to LC-MS/MS and subsequent bioinformatic analysis. Results. Proteomic profiling identified 107 significantly changed proteins between the inactive stage of TAO patients and healthy cases. Among these proteins, 62 were upregulated, and 45 were downregulated in TAO cases compared to healthy individuals. Enrichment analysis revealed that the immune system, cell cycle, metabolism (carbohydrate metabolism and metabolism of cofactors and vitamins), protein synthesis and degradation might play a vital role in the progress of inactive TAO. The present investigation represents the first proteomic tear study of TAO patients in the inactive stage. Conclusion. The results shed light on the differences between inactive TAO patients and healthy cases, thus enabling us to understand better the molecular mechanisms and potential targets for the treatment of inactive TAO.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Psychosocial factors in subjects with thyroid-associated ophthalmopathy
    Kahaly, GJ
    Hardt, J
    Petrak, F
    Egle, UT
    THYROID, 2002, 12 (03) : 237 - 239
  • [42] THYROID-ASSOCIATED OPHTHALMOPATHY - PATHOGENESIS AND CLINICAL MANAGEMENT
    PERROS, P
    KENDALLTAYLOR, P
    BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1995, 9 (01): : 115 - 135
  • [43] Thyroid-associated ophthalmopathy: physiopathology, endocrine status
    Teissier, MP
    Lopez, S
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2004, 27 (07): : 806 - 809
  • [44] An update on thyroid-associated ophthalmopathy in children and adolescents
    Szczapa-Jagustyn, Justyna
    Gotz-Wieckowska, Anna
    Kociecki, Jaroslaw
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2016, 29 (10): : 1115 - 1122
  • [45] ANTIBODIES TO ORBITAL TISSUES IN THYROID-ASSOCIATED OPHTHALMOPATHY
    PERROS, P
    KENDALLTAYLOR, P
    ACTA ENDOCRINOLOGICA, 1992, 126 (02): : 137 - 142
  • [46] Role of cytokines in the pathogenesis of thyroid-associated ophthalmopathy
    Hiromatsu, Y
    Kaku, H
    Miyake, I
    Murayama, S
    Soejima, E
    THYROID, 2002, 12 (03) : 217 - 221
  • [47] CLINICAL AND THERAPEUTIC PARTICULARITIES IN THE THYROID-ASSOCIATED OPHTHALMOPATHY
    Popescu, Mihaela
    Mocanu, Carmen
    SGEM 2016, BK 1: PSYCHOLOGY AND PSYCHIATRY, SOCIOLOGY AND HEALTHCARE, EDUCATION CONFERENCE PROCEEDINGS, VOL II, 2016, : 265 - 272
  • [48] Intraorbital Electroacupuncture Therapy for Thyroid-associated Ophthalmopathy
    Zhou, Ling-Yun
    Su, Chang
    Li, Xue-Mei
    Liu, Tie-Juan
    Zhao, Ming
    CHINESE MEDICAL JOURNAL, 2017, 130 (15) : 1884 - 1885
  • [49] 131I and thyroid-associated ophthalmopathy
    Rasmussen, ÅK
    Nygaard, B
    Feldt-Rasmussen, U
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (02) : 155 - 160
  • [50] Thyroid-associated ophthalmopathy: the role of oxidative stress
    Ma, Chao
    Li, Haoyu
    Lu, Shuwen
    Li, Xian
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15